Skin & hair

Clearing Acne Safely While Pregnant

Save

Pregnancy narrows the acne-treatment menu rather than closing it. This article explains why isotretinoin is the one non-negotiable exception, how topical treatment differs from oral treatment in what reaches a fetus, and what questions are worth bringing to a prescriber managing acne alongside a pregnancy.

Last updated: July 2026History

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Why Pregnancy Changes the Acne Playbook

Almost every systemic medication crosses the placenta to some degree, and pregnancy is a population where randomized safety trials are, for ethical reasons, essentially never run. So the standard of care for treating almost anything during pregnancy leans conservative by default, favoring the option with the longest track record and the least systemic absorption over the single most potent one. Acne treatment sits inside that same general logic: the acne treatment ladder spans purely topical options through oral, systemic medications, and pregnancy is exactly the variable that changes which rung makes sense 1.

None of this means acne has to go untreated for nine months. It means the choice of what to use, and when, becomes a conversation that includes whoever is managing the pregnancy, not just whoever is managing the skin — and that "safe" is not a fixed label on a product so much as a judgment made for a specific stage of pregnancy and a specific person's history.

That also means information gathered before pregnancy, including anything encountered while researching general acne treatment, needs to be revisited rather than assumed to still apply. A routine that was entirely reasonable last year is a new question the moment pregnancy, or an active attempt to conceive, enters the picture.

The One Absolute: Isotretinoin

Of every acne treatment, isotretinoin is the one with a genuinely bright line. It is teratogenic — capable of causing severe birth defects — and for that reason it is dispensed in the United States only through the FDA-mandated iPLEDGE program, which requires prescriber, patient, and pharmacy registration along with pregnancy-prevention measures, including pregnancy testing and contraception, for anyone who can become pregnant 2. This is not a precaution layered on top of isotretinoin treatment — it is a structural requirement built into how the drug can legally be prescribed at all.

Anyone taking isotretinoin who becomes pregnant, suspects pregnancy, or is actively planning a pregnancy is directed by the iPLEDGE program itself to contact the prescribing clinician right away; the program has a defined process for exactly this scenario, because it is a scenario the program is built around.

Where the Real Conversation Usually Starts: Topical vs. Systemic

Topical treatment — applied directly to the skin — generally reaches the bloodstream, and therefore the fetus, in far smaller amounts than an oral medication taken systemically. That distinction is a large part of why the treatment-ladder conversation during pregnancy tends to concentrate on the systemic tier rather than on topical treatment as a category. The guideline's topical tier includes benzoyl peroxide, topical antibiotics, and azelaic acid, among other ingredients, alongside an oral tier that spans tetracyclines, hormonal therapy, and isotretinoin 1.

Oral tetracyclines are a useful example of how caution plays out even outside of pregnancy: dermatology guidance already treats them as a limited-duration bridge rather than a long-term drug, layered onto topical therapy and then stopped, for antibiotic-stewardship reasons that have nothing to do with pregnancy specifically 3. That existing caution around duration and systemic exposure is part of why oral antibiotic choices get a second look, and are sometimes substituted, once pregnancy enters the picture.

What This Looks Like in Practice

The most useful single step is disclosure, made early and updated as things change: naming every product in use, prescription and over-the-counter, to both the prescriber managing acne and whoever is managing the pregnancy or pregnancy planning. A short list assembled from memory during a rushed visit is a worse starting point than an actual list brought in.

For isotretinoin specifically, that conversation needs to happen before conception is attempted, not after a positive test, given the drug's teratogenicity and the pregnancy-prevention infrastructure built around it 2. For other treatments, the timeline is less rigid, but the same principle holds: a plan made in coordination with the clinicians involved holds up better than one assembled from general information alone, however carefully sourced. It also helps to know upfront that the acne treatment timeline is measured in months, not days, so patience is warranted no matter which option is ultimately chosen.

Skin Changes During Pregnancy Itself

Many people notice their skin behaves differently once pregnant — sometimes clearer, sometimes with a new flare that wasn't a problem before — and it isn't unusual for whatever new pattern emerges to shift again in the months after delivery. That variability is part of why patience is a reasonable stance during pregnancy specifically: a flare that shows up in one trimester does not necessarily predict how skin will behave in the next one, or postpartum.

Skin care that doesn't involve a systemic medication — gentle cleansing, a non-comedogenic moisturizer, sun protection — remains a reasonable baseline throughout pregnancy regardless of what happens with active treatment, and it is worth continuing even while other decisions are still being worked out with a prescriber.

Expecting some uncertainty during this stretch is realistic rather than pessimistic. A treatment plan that gets adjusted once, or even a few times, over the course of a pregnancy as symptoms shift is a normal part of the process, not a sign that the previous plan was wrong.

Questions Worth Bringing to the Visit

A conversation about acne treatment during pregnancy tends to go better with specific questions ready, rather than starting from a blank slate: whether a product already being used needs to pause or can continue, whether it's absorbed enough to matter for the current stage of pregnancy, whether waiting until a specific trimester or until after delivery changes the calculus, and what the plan is if pregnancy happens sooner than expected while on a treatment that has a required waiting period beforehand.

Bringing an actual list of every product in use — including over-the-counter cleansers and spot treatments, not just prescriptions — gives the clinician a complete picture to work from, rather than one pieced together during a short visit.

Common questions

No. Isotretinoin is teratogenic and is dispensed in the U.S. only through the FDA's iPLEDGE program, which requires pregnancy testing and contraception for anyone who can become pregnant and has a defined process for suspected or confirmed pregnancy during treatment. This is the one bright line in acne treatment during pregnancy.

That depends on which products and how they're used, which is exactly why disclosing every product — prescription and over-the-counter — to whoever is managing the pregnancy is the useful first step, rather than pausing or continuing everything on a guess. Topical treatment generally reaches the bloodstream in much smaller amounts than an oral medication, which is often where the conversation starts.

For isotretinoin specifically, yes — the drug's teratogenicity and the pregnancy-prevention structure built around it mean conception is not attempted while on it. For other treatments, the timeline is less rigid and is worked out with the prescriber based on what's being used.

It varies. Some people notice clearer skin during pregnancy; others see a new flare that wasn't a problem before. Either pattern is common, and it isn't unusual for skin to shift again in the months after delivery. Whichever direction it goes, the treatment options available during that stretch are still shaped by the same pregnancy-first considerations described here.

Breastfeeding raises a related but separate set of questions from pregnancy, since what passes into breast milk is not the same as what crosses the placenta. It's worth raising explicitly with a prescriber rather than assuming pregnancy guidance carries over automatically.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

The One Non-Negotiable: Isotretinoin and Pregnancy

  • a missed period or positive pregnancy test while taking isotretinoin
  • starting or continuing isotretinoin without an active, confirmed contraception plan
  • a new pregnancy discovered while on any oral acne medication, not isotretinoin alone
  • uncertainty about whether a current product is appropriate for the current stage of pregnancy

This article explains the general shape of the decision, not a specific recommendation for any individual; a dermatologist coordinating with the pregnancy care team is who can weigh a specific product against a specific stage of pregnancy.

Did this answer your question?

References

  1. 1.Reynolds RV, Yeung H, Cheng CE, et al. (2024). Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. PMID 38300170Supports the existence of a topical-through-systemic acne treatment ladder, including which ingredients and drug classes make up each tier.
  2. 2.U.S. Food and Drug Administration (2023). iPLEDGE Risk Evaluation and Mitigation Strategy (REMS). U.S. Food and Drug Administration. linkSupports that isotretinoin is teratogenic and dispensed only through the FDA-mandated iPLEDGE program requiring pregnancy-prevention measures.
  3. 3.Armstrong AW, Hekmatjah J, Kircik LH (2020). Oral Tetracyclines and Acne: A Systematic Review for Dermatologists. Journal of Drugs in Dermatology. PMID 33196746Supports that oral tetracyclines are used for a limited duration as an antibiotic-stewardship matter, context for why oral antibiotic choices are reconsidered during pregnancy.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy